Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia
- PMID: 17080004
- DOI: 10.1097/01.CCM.0000249826.81273.E4
Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia
Abstract
Objective: Early recognition of predictors of unfavorable evolution of ventilator-associated pneumonia (VAP) might prompt therapeutic measures that might improve outcome. The objective of this study was to describe resolution of VAP variables and to determine early predictors of VAP recurrence and death.
Design and setting: Description of the natural course of VAP resolution and multivariable analyses of predictors of VAP recurrence and death by day 28 after VAP onset based on the 401 patients included in the PNEUMA trial, a multiple-center, randomized study comparing 8 vs. 15 days of antibiotics for microbiologically proven VAP. Every patient included in that trial had received appropriate empirical antibiotics.
Measurements and main results: By day 28 after VAP onset, 27% of patients had VAP recurrence and 18% had died. On day 8 after VAP onset, predictors of VAP recurrence included intensive care unit admission Simplified Acute Physiology Score II (odds ratio [OR], 1.02), radiologic score (OR, 1.17), temperature (OR, 1.34), nonfermenting Gram-negative bacilli (OR, 2.00) or methicillin-resistant Staphylococcus aureus (OR, 2.50) as pathogens responsible for VAP, and mechanical ventilation dependency (OR, 2.08). Day 8 predictors of 28-day death were age (OR, 1.06), female sex (OR, 2.30), Sepsis-Related Organ Failure Assessment score (OR, 1.26), and nonfermenting Gram-negative bacilli (OR, 2.83) as pathogens responsible for VAP. However, the duration of antimicrobial therapy (8 vs. 15 days) was not associated with any of the studied adverse outcomes.
Conclusions: For patients benefiting from appropriate empirical antibiotics for VAP, early predictors of infection recurrence or death included demographic characteristics, such as age or female sex, disease severity at VAP onset, nonfermenting Gram-negative bacilli or methicillin-resistant S. aureus as VAP-causative pathogens, prolonged mechanical ventilation dependency, persistent fever, and severity of lung injury. Future studies should attempt to determine whether specific diagnostic or therapeutic strategies could markedly improve VAP outcomes when early criteria for treatment failure are present.
Similar articles
-
Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.J Med Assoc Thai. 2010 Jan;93 Suppl 1:S126-38. J Med Assoc Thai. 2010. PMID: 20364567
-
Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia.Crit Care Med. 2007 Sep;35(9):2064-70. doi: 10.1097/01.CCM.0000277042.31524.66. Crit Care Med. 2007. PMID: 17581489
-
Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.Crit Care Med. 2006 Mar;34(3):700-6. doi: 10.1097/01.CCM.0000201885.57697.21. Crit Care Med. 2006. PMID: 16505656
-
Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia.Semin Respir Crit Care Med. 2009 Feb;30(1):116-23. doi: 10.1055/s-0028-1119815. Epub 2009 Feb 6. Semin Respir Crit Care Med. 2009. PMID: 19199193 Review.
-
The microbiology of ventilator-associated pneumonia.Respir Care. 2005 Jun;50(6):742-63; discussion 763-5. Respir Care. 2005. PMID: 15913466 Review.
Cited by
-
Incidence, bacteriology, and clinical outcome of ventilator-associated pneumonia at tertiary care hospital.J Nat Sci Biol Med. 2017 Jan-Jun;8(1):46-55. doi: 10.4103/0976-9668.198360. J Nat Sci Biol Med. 2017. PMID: 28250674 Free PMC article.
-
Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality.Eur J Clin Microbiol Infect Dis. 2013 Mar;32(3):413-20. doi: 10.1007/s10096-012-1758-8. Epub 2013 Jan 24. Eur J Clin Microbiol Infect Dis. 2013. PMID: 23344827
-
Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.Cochrane Database Syst Rev. 2015 Aug 24;2015(8):CD007577. doi: 10.1002/14651858.CD007577.pub3. Cochrane Database Syst Rev. 2015. PMID: 26301604 Free PMC article.
-
How to approach a patient hospitalized for pneumonia who is not responding to treatment?Intensive Care Med. 2025 May;51(5):893-903. doi: 10.1007/s00134-025-07903-3. Epub 2025 May 24. Intensive Care Med. 2025. PMID: 40411623 Free PMC article. Review.
-
Clinical pulmonary infection score and a spot serum procalcitonin level to guide discontinuation of antibiotics in ventilator-associated pneumonia: a study in a single institution with high prevalence of nonfermentative gram-negative bacilli infection.Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618760134. doi: 10.1177/1753466618760134. Ther Adv Respir Dis. 2018. PMID: 29506460 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical